We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

Key drugs Blenrep and Depemokimab show significant potential, with impressive Phase 3 results, expected to boost GSK's revenues by an extra £7 billion. Despite some IRA and clinical trial risks ...

The presentation was sent to our distribution list by email, and you can also find it on gsk.com ... will differentiate based on clinical data. And the market research that we have in these ...

GSK has recently launched a phase 3 trial, Dreamm-10 ... peak sales from Nucala and the near-market long-acting IL-5 drug depemokimab, will help boost the contribution of GSK's specialty medicines ...

Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More. GSK (LSE:GSK) shares ended 2024 on a sour ...

GSK plans to buy back $2.50 billion in shares ... the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

GSK reported Q4 sales of $10.40B, surpassing estimates of $9.58B, while core EPS of $0.59 beat the consensus of $0.43 despite a 10% decline. Vaccine sales fell 14% to £2.21B, with Arexvy sales ...

Pharmaceuticals giant GlaxoSmithKline (GSK.L ... with 71 specialty medicines and vaccines now in clinical development. As a result, the company said it is targeting total sales of more than £40 ...

GSK is prioritizing development of its hepatitis ... The company still has another HIV capsid protein inhibitor in multiple clinical trials in the form of VH3739937. The final drug to be pulled ...

GSK also hiked its 2031 sales target, which it said reflected “late-stage pipeline progress”. Turnover is now tipped at £40bn, a £2bn upgrade from prior targets. Today, the company has 71 Specialty ...

Early results from a pilot clinical trial in three human volunteers with SMA show that one month of regular neurostimulation sessions improved motoneuron function, reduced fatigue and improved ...